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Introduction: A growing body of evidence shows the prognostic value of oxygen uptake effi ciency 
slope (OUES), a cardiopulmonary exercise test (CPET) parameter derived from the logarithmic 
relationship between O2 consumption (VO2) and minute ventilation (VE) in patients with chronic 
heart failure (CHF). 
Objective: To evaluate the prognostic value of a new CPET parameter — peak oxygen uptake 
effi ciency (POUE) — and to compare it with OUES in patients with CHF. 
Methods: We prospectively studied 206 consecutive patients with stable CHF due to dilated 
cardiomyopathy — 153 male, aged 53.3±13.0 years, 35.4% of ischemic etiology, left ventricular 
ejection fraction 27.7±8.0%, 81.1% in sinus rhythm, 97.1% receiving ACE-Is or ARBs, 78.2% 
beta-blockers and 60.2% spironolactone — who performed a fi rst maximal symptom-limited 
treadmill CPET, using the modified Bruce protocol. In 33% of patients an cardioverter-
defi brillator (ICD) or cardiac resynchronization therapy device (CRT-D) was implanted during 
follow-up.
 Peak VO2, percentage of predicted peak VO2, VE/VCO2 slope, OUES and POUE were analyzed. 
OUES was calculated using the formula VO2 (l/min) = OUES (log10VE) + b. POUE was calculated 
as pVO2 (l/min) / log10peakVE (l/min). Correlation coeffi cients between the studied parameters 
were obtained. The prognosis of each variable adjusted for age was evaluated through Cox 
proportional hazard models and R2 percent (R2%) and V index (V6) were used as measures of the 
predictive accuracy of events of each of these variables. Receiver operating characteristic (ROC) 
curves from logistic regression models were used to determine the cut-offs for OUES and POUE.
Results: pVO2: 20.5±5.9; percentage of predicted peak VO2: 68.6±18.2; VE/VCO2 slope: 30.6±8.3; 
OUES: 1.85±0.61; POUE: 0.88±0.27. During a mean follow-up of 33.1±14.8 months, 45 (21.8%) 
patients died, 10 (4.9%) underwent urgent heart transplantation and in three patients (1.5%) a 
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Introduction
Several cardiopulmonary exercise testing (CPET)-derived 
parameters have an established role in prognostic 
stratifi cation of patients with chronic heart failure (CHF). 
In recent years the number of these variables has continued 
to grow. 
In 1996, Baba et al.1 reported a new CPET-derived 
parameter, oxygen uptake effi ciency slope (OUES), a marker 
of ventilatory effi ciency that represents the relationship 
between minute ventilation and oxygen uptake during 
exercise. In that study, OUES showed a highly significant 
correlation with peak oxygen uptake (VO2) in a group of 
patients, predominantly children, with CHF. 
of this combined event; however, VE/VCO2 slope was most strongly associated with events (HR 
11.14). In this population, POUE was associated with a higher risk of events than OUES (HR 
9.61 vs. 7.01), and was also a better predictor of events (R2: 28.91 vs. 22.37). 
Conclusion: POUE was more strongly associated with death, urgent heart transplantation and 
implantation of a left ventricular assist device and proved to be a better predictor of events 
than OUES. These results suggest that this new parameter can increase the prognostic value of 
CPET in patients with CHF.
© 2010 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L. All rights reserved.
Valor prognóstico de um novo parâmetro da prova de esforço cardiorrespiratória 
na insufi ciência cardíaca crónica: a efi ciência do consumo de oxigénio no pico 
de esforço — comparação com o declive da efi ciência de consumo de oxigénio
Resumo
Introdução: Vários estudos demonstraram que o declive da efi ciência de consumo de O2 (DECO), 
derivado da relação logarítmica entre o consumo de O2 (VO2) e a ventilação minuto (VE) durante 
a prova de esforço cárdiorrespiratória (PECR), apresenta valor prognóstico independente de 
eventos em doentes (dts) com insufi ciência cardíaca (IC) crónica. 
Objectivos: Avaliar o valor prognóstico de um novo parâmetro da PECR, a efi ciência do consumo 
de O2 no pico de esforço (ECOP) e compará-lo com o do DECO em dts com IC.
Métodos: Estudámos, prospectivamente, 206 dts com miocardiopatia dilatada e IC estável (153 do 
sexo masculino, 53,3±13,0 anos, 35,4% isquémica, fracção de ejecção do VE 27,7±8,0%, 81,1% em 
ritmo sinusal, 97,1% sob i-ECA e/ou ARAII, 78,2% sob bloqueadores beta, 60,2% sob espironolactona), 
que efectuaram uma primeira PECR (máxima limitada por sintomas, em tapete rolante, protocolo 
de Bruce modifi cado). Em 33% dos dts foi implantado um cardioversor-desfi brilhador (CDI) ou um 
sistema de ressíncronização cardíaca com CDI (CRT-D) durante o seguimento. 
 Analisámos o VO2 de pico, a percentagem do VO2 máximo teórico atingida, o declive VE/VCO2, 
o DECO e o ECOP. O DECO foi calculado através da fórmula VO2 (L/min) = DECO (log10VE) + b. O 
ECOP foi calculado como ECOP=VO2p (L/min) / log10VE máximo (L/min). Os coefi cientes de 
correlação entre os parâmetros estudados foram calculados. O prognóstico de cada variável 
ajustado por idade foi avaliado através dos modelos proporcionais de Cox e o R2 percentual e o 
V index foram utilizados como medidas de acuidade preditiva de eventos de cada uma destas 
variáveis. Recorremos às curvas ROC dos modelos de regressão logística para determinar o 
cut-off de cada parâmetro. 
Resultados: VO2p: 20,5 ± 5,9; percentagem do VO2 máximo teórico atingida: 68,6 ± 18,2; declive 
VE/VCO2: 30,6 ± 8,3; DECO: 1,85 ± 0,61; ECOP: 0,88 ± 0,27. Num seguimento médio de 
33,1±14,8 meses após a inclusão no estudo, faleceram 45 dts (21,8%), 10 (4,9%) foram submetidos 
a transplantação cardíaca urgente e em três dts (1,5%) foi implantado um sistema de assistência 
ventricular. Todos os parâmetros estudados foram preditores independentes deste evento 
combinado. No entanto, o declive VE/VCO2 foi o parâmetro mais associado a eventos (RR 11,14). 
O ECOP associou-se, nesta população, a um maior risco de eventos que o DECO (RR 9,61 versus 
7,01), tendo-se revelado também um melhor preditor de eventos (R2: 28,91 versus 22,37).
Conclusão: O ECOP associou-se mais a probabilidade de morte, transplante cardíaco urgente e 
implantação de sistema de assistência ventricular e revelou-se um melhor preditor de eventos 
que o DECO. Os resultados obtidos sugerem que este novo parâmetro pode aumentar o valor 
prognóstico das PECR em doentes com IC.
© 2010 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L. Todos os direitos 
reservados.
PALAVRAS-CHAVE
Insufi ciência cardíaca; 
Prova de esforço; 
Prognóstico
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Although this first study and others2 emphasized the 
value of OUES as a submaximal, effort-independent 
and objective parameter to estimate cardiorespiratory 
functional reserve, more recently it has been claimed to 
have enhanced prognostic value in CHF patients3,4. Myers et 
al.5, when defi ning a CPET score for predicting outcomes in 
this context, considered OUES to be a stronger predictor of 
risk than peak VO2.
The aim of the present study was to evaluate the 
prognostic value, in CHF patients, of another new CPET 
parameter of ventilatory effi ciency proposed by our group 
— peak oxygen uptake efficiency (POUE). We set out to 
compare this easily obtained parameter with OUES, as 
well as with the prognostic value of other CPET-derived 
variables.
Methods
This study was a single-center analysis that included patients 
with CHF due to left ventricular systolic dysfunction (LVSD) 
referred to our laboratory for a fi rst CPET evaluation. Only 
patients with left ventricular ejection fraction <40% and free 
of exercise-limiting comorbidities such as cerebrovascular 
disease, musculoskeletal impairment, or peripheral 
vascular disease were included. Also, only patients with no 
signifi cant respiratory disease, excluded by clinical history, 
physical examination and chest X-ray, were considered for 
the study. Patients gave informed consent for participation.
We prospectively studied 206 patients with CHF due 
to LVSD, 35.4% of ischemic etiology. There were 153 men 
(74.3%), mean age was 53.3±13.0 years (range 21 to 80), 
body mass index 26.4±4.2 kg/m2 (17.1 to 38.1), 81.1% in 
sinus rhythm, echocardiographic left ventricular end-diastolic 
dimension 39.6±5.7 mm/m2 (32 to 69) and ejection fraction 
27.7±8.0% (10 to 39). According to the referring physician, 
78.2% of the patients were in New York Heart Association 
class ≤II. Ninety-seven percent were medicated with 
an angiotensin-converting enzyme inhibitor or/and an 
angiotensin receptor blocker, 89.0% with a diuretic, 78.2% with 
a beta-blocker and 60.2% with spironolactone. Thirty-three 
percent presented or were treated during follow-up with 
an implantable cardioverter-defi brillator (ICD) or a cardiac 
resynchronization plus ICD device. The characteristics of the 
study population are summarized in Table 1.
All subjects underwent maximal symptom-limited 
treadmill CPET, using the modified Bruce protocol 
(GE Marquette Series 2000 treadmill). The 12-lead 
electrocardiogram and heart rate were recorded 
continuously during the test and continued for six minutes 
of the recovery period. Blood pressure was measured at 
rest, during the last 30 seconds of each stage, at peak 
exercise and at the first, third and sixth minute of the 
recovery phase.
In no case did altered blood pressure, arrhythmia, chest 
pain or electrocardiographic changes lead to interruption 
of the test, in accordance with international standards7. All 
studies were, accordingly, interrupted by subjective fatigue 
or dyspnea preventing the patient from continuing the 
exercise. No medication was discontinued before the test.
Minute ventilation (VE in l/min), oxygen uptake (VO2 in 
l/min) and carbon dioxide production (VCO2 in l/min) were 
acquired breath-by-breath, using a SensorMedics Vmax 
229 gas analyzer. Gas analysis was preceded by calibration 
of the equipment and began three minutes prior to exercise.
Patients were encouraged to perform exercise until 
the VCO2/VO2 ratio (respiratory exchange ratio — RER) 
was ≥1.10. Besides RER, other derived variables were 
calculated, including ventilatory equivalent for oxygen (VE/
VO2) and for carbon dioxide (VE/VCO2).
Peak VO2 was expressed as the highest VO2 attained during 
the fi nal 30 seconds of exercise2. For prognostic evaluation 
only peak VO2 normalized for body mass (ml/kg/min) — for 
fat-free mass in obese patients (body mass index >30 kg/
m2) — was considered. Predicted peak VO2 (in l/min, and 
in ml/kg/min) and the percentages of the predicted values 
achieved were calculated by the system software.
The ventilatory anaerobic threshold (AT) was determined 
using the V-slope method, and corrected, when necessary, 
using the VE/VO2 versus VE/VCO2 criterion and/or the 
end-tidal oxygen and carbon dioxide partial pressures 
method1,8. Inability to achieve AT was an exclusion criterion.
The VE/VCO2 slope was calculated as the slope of the 
regression line relating VE to VCO2 during exercise, with 
data obtained over the complete duration of exercise9.
OUES was calculated by averaging VE and VO2 over 
10-second intervals6, for the entire exercise duration, using 
the following equation: VO2 (l/min) = a (log10VE) + b, where 
a = OUES1. POUE was calculated as peak VO2/log10 peak VE.
In a subset of patients — the last 50 patients (39 [78%] 
male, age 54.8±13.3 years) — a new parameter of ventilatory 
efficiency, oxygen uptake efficiency at AT (OUEAT) was 
calculated, as OUEAT=VO2 (l/min) at AT / log10 VE at AT.
Patients were followed for major cardiac events (death, 
urgent transplantation or left ventricular assist device 
implantation). Mean follow-up in patients without events 
was 33.1±14.8 months (9 to 69).
Table 1 Characteristics of the study population
Age (years) 53.3±13.0
Male, n (%) 153 (74.3%)
Body mass index (kg/m2) 26.4±4.2
Ischemic etiology of LVSD, n (%)  74 (35.4%)
NYHA functional class ≤II, n (%) 161 (78.2%)
Sinus rhythm, n (%) 167 (81.1%)
LV end-diastolic dimension (mm/m2) 39.6±5.7
LV ejection fraction (%) 27.7±8.0
Serum creatinine (mg/dl) 1.1±0.3
Hemoglobin (g/dl) 13.7±1.6
NT-proBNP (pg/ml) 2297±2349
Prescribed ACE-I and/or ARB, n (%) 200 (97.1%)
Prescribed diuretic, n (%) 183 (89.0%)
Prescribed beta-blocker, n (%) 161 (78.2%)
Prescribed spironolactone, n (%) 124 (60.2%)
Treated with ICD or CRT-ICD, n (%)  68 (33.0%)
ACE-I: angiotensin-converting enzyme inhibitor; 
ARB: angiotensin receptor blocker; CRT: cardiac resynchronization 
therapy; ICD: implantable cardioverter-defi brillator; 
LV: left ventricular; LVSD: left ventricular systolic dysfunction; 
NT-proBNP: N-terminal pro-B-type natriuretic peptide; 
NYHA: New York Heart Association.
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Statistical analysis
Results are expressed as means ± one standard deviation. 
Correlations between variables were assessed by linear 
regression analysis. Correlation coeffi cients were compared 
using the Fisher r-to-z transformation. A p value of <0.05 
was considered statistically signifi cant.
The prognostic value of each variable was assessed 
through Cox proportional hazard models adjusted for age. 
R2 percent (R2%) and V index (V6) were used as measures 
of the predictive accuracy of each of these variables. ROC 
(receiver operating characteristic) curves from logistic 
regression models were used to fi nd cut-offs for OUES and 
POUE and to evaluate their specifi city and sensitivity.
All tests were performed using the statistical program R 
Development Core Team. R: (A language and environment 
for statistical computing. R Foundation for Statistical 
Computing, Vienna, Austria).
Results
The CPET results are presented in Table 2.
A signifi cant and strong correlation was found between 
OUEP and OUES — r=0.914, r2=0.836, p<0.001 (Figure 1). 
The correlations between OUES and OUEP with peak 
VO2 expressed in l/min were, respectively, r=0.876, r2=0.768 
(p<0.001) and r=0.983, r2=0.966 (p<0.001) (comparison 
between correlations: p<0.001). For the same variables t he 
correlations with peak VO2 in ml/kg/min were, respectively, 
r=0.744, r2=0.554 (p<0.001) and 0. 834, r2=0.696 (p<0.001) 
(comparison between correlations: p=0.0147).
Peak VO2 also presented significant correlations with 
VE/VCO2 slope, the highest being when it was expressed 
in ml/kg/min — r=0.624, r2=0.389 (p<0.001), but this 
correlation was weaker than any obtained between peak 
VO2 and OUES or OUEP (p<0.025).
During follow-up, 45 patients (21.8%) died, 10 (4.9%) 
underwent urgent heart transplantation and in three 
patients (1.5%) a left ventricular assist device was implanted 
as a bridge for transplantation. All studied parameters were 
shown to be independent predictors of the combined event 
(Table 3, Figure 2).
Of all the studied parameters, VE/VCO2 slope was the most 
closely associated with events, followed by percentage of 
 predicted peak VO2 and POUE (hazard ratio 11.14, 11.06 and 
9.61 respectively). These three variables were also the best 
predictors of events (Table 3). In this population, POUE was 
more strongly associated with increased risk of death, urgent 
transplantation or left ventricular assist device implantation 
when compared directly with OUES (HR 9.61 vs. 7.01), and 
also proved to be a better predictor of events (R2% 28.91 vs. 
R2% 22.37 and V6 0.31 vs. V6 0.23). Figure 2 shows Kaplan-
Meier curves for the studied parameters.
The ROC curve plotted for OUES showed an area under the 
curve (AUC)=0.819. The AUC for POUE was similar (0.815) 
(Figure 3). For OUES a cut-off value of 1.60 had sensitivity 
of 76% and specifi city of 76% for the occurrence of events. 




Peak VO2  9.26 5.21-16.47 26.79 0.28
% of predicted peak VO2 11.06 5.93-20.64 30.91 0.31
VE/VCO2 slope 11.14 6.06-20.51 30.88 0.34
Oxygen uptake effi ciency 
 slope
 7.01 3.84-12.78 22.37 0.23
Oxygen uptake effi ciency 
 at peak exercise
 9.61 5.34-17.27 28.91 0.31
CI: confi dence interval; V6: V index.
Table 2 Exercise characteristics
 Mean±SD Minimum and maximum
Exercise duration (min) 10.6±4.2  1.6 to 20.8
% of predicted maximal heart rate 84.5±14.9  48.1 to 139.6
Peak VO2 in l/min 1.53±0.57 0.51 to 3.74
% of predicted peak VO2 in l/min 66.5±20.5  26 to 128
Peak VO2 in ml/kg/min 20.5±5.9  8.6 to 40.6
% of predicted peak VO2 in ml/kg/min 68.6±18.2  30 to 121
Peak respiratory exchange ratio 1.11±0.08 1.00 to 1.41
VE/VCO2 slope 30.6±8.3 18.4 to 63.6
Oxygen uptake effi ciency slope 1.85±0.61 0.48 to 4.56
Oxygen uptake effi ciency at peak exercise 0.88±0.27 0.34 to 1.85
VCO2: carbon dioxide production; VE: minute ventilation; VO2: oxygen uptake.
Figure 1 Correlation between OUES and POUE. OUES: oxygen 















Document downloaded from http://www.elsevier.pt, day 08/11/2011. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure 785
For POUE a cut-off value of 0.73 showed sensitivity of 72% 
and specifi city of 86% for events.
In a subset of 50 patients we evaluated OUEAT — 
mean=0.79±0.22 (0.32 to 1.47). OUEAT correlated both 
with OUES (r=0.901, r2=0.811, p<0.001) and with OUEP 
(r=0.959, r2=0.919, p<0.001), the latter correlation 
being stronger (p<0.001). OUEAT also showed a signifi cant 
correlation with peak VO2 (r=0.930, r2=0.966, p<0.001), 
and this correlation was also stronger than that between 
OUES and peak VO2 (p=0.0025), although weaker than for 
OUEP (p<0.001).
Discussion
OUES is a non-linear measure of the ventilatory response 
to exercise derived from the single-segment logarithmic 















































































































































































Figure 2 Kaplan-Meier curves for the studied parameters. A: Peak VO2 (ml/kg/min). B: Percentage of predicted peak VO2. C: VE/
VCO2 slope. D: OUES. E: POUE.
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during incremental exercise1,2. It incorporates, in a single 
index, not only cardiovascular and peripheral factors that 
determine oxygen uptake, but also pulmonary factors 
that influence ventilatory response to exercise. It is a 
submaximal and effort-independent parameter, and, unlike 
pVO2, does not rely on the last segment of the exercise. 
Instead, it uses the whole of the exercise data, even if 
submaximal, which can be an advantage in patients who do 
not tolerate maximal exertion or with a low motivation to 
fi nish the test.
On the basis of this logarithmic relation, log VE at 
peak exercise and at ventilatory anaerobic threshold was 
used to calculate, respectively, OUEP and OUEAT. Strong 
correlations were found between OUES, OUEP and OUEAT, 
and also between these three variables of ventilatory 
effi ciency and peak VO2. The prognostic value of OUEP in 
the study population was at least similar to that of OUES 
— OUEAT was only calculated in a subset of patients, and 
its prognostic value was not analyzed. OUEP is more easily 
obtained than OUES, and our results suggest that in maximal 
CPET it can replace it for prognostic evaluation.
In our study the average of VE and VO2 over 10-second 
intervals was used to calculate OUES, rather than on a 
breath-by-breath basis. This method has been used by 
others6,10.
Figure 3 ROC curves for OUES and POUE. OUES: oxygen uptake 
effi ciency slope; POUE: peak oxygen uptake effi ciency.
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It should be emphasized that the established role of 
OUES as a submaximal and objective parameter to estimate 
cardiorespiratory functional reserve1,2 was not called into 
question by our study, as only its value for the entire 
exercise duration was analyzed.
Ventilatory efficiency has been more widely evaluated 
by the relation between VE and VCO2. Both the value 
obtained from the slope of the regression line relating VE 
to VCO2 during exercise — the VE/VCO2 slope — and their 
simple ratio at peak exercise showed prognostic value 
in patients with CHF due to LVSD. Arena et al.10 found 
that, although not identical, VE/VCO2 slope and ratio at 
peak exercise provide similar prognostic information. 
Nevertheless, ventilatory efficiency has been typically 
expressed as the VE/VCO2 slope, and several studies have 
reported it as being the strongest prognostic marker in 
patients with CHF when assessed at peak exercise11,12. In 
our study we did not evaluate the VE/VCO2 ratio at peak 
exercise. The VE/VCO2 slope provided greater prognostic 
information than peak VO2 and OUES, confi rming the results 
of other authors13,14.
We studied a young population with CHF. This may 
explain why most of the patients were referred for heart 
transplantation evaluation. It may also explain the stronger 
prognostic value of the percentage of predicted peak 
VO2 achieved over the absolute value of peak VO2. A study 
by Bard et al.11 evaluated a typical population referred 
for heart transplantation in the United States of America, 
with mean age 50.6±10.2 years, 72% men, 55% with LVSD 
of nonischemic etiology, left ventricular ejection fraction 
21.5±7.7%, peak VO2 17.3±5.0 ml/kg/min, and percentage 
of predicted peak VO2 achieved 58.7±18.2%. Comparison 
with our study population prompts the comment that in 
Portugal the most important factor leading to referral for 
heart transplantation is left ventricular ejection fraction, 
even more than the patient’s functional capacity.
Conclusions
According to our results, for prognostic assessment in 
patients with CHF due to LVSD, OUEP is superior to OUES and 
even to peak VO2, and inferior to VE/VCO2 slope. However, 
these are the results of a single-center study, and should be 
confi rmed or refuted by others. 
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